Canada Goose Reports Q4, FY2026 Results: Revenue Growth Broad-Based, Margins Under Pressure

What happened

Canada Goose reported Q4 and full-year fiscal 2026 results, with revenue growth described as broad-based across regions and channels, driven by improved DTC conversion and wholesale performance. The company highlighted 'meaningful progress' in its strategic execution, but the Master Report's analysis of prior quarters warns that revenue gains have been accompanied by SG&A deleverage and elevated marketing spend. Q3 FY2026 saw DTC comps rise 6.3% but adjusted EBIT margin fall to 29.3% from 33.8%, a pattern likely persisting in Q4 as management continues 'significant marketing investments.' The DeepValue Master Report rates the stock a WAIT with conviction 4.0, seeing no margin of safety at current valuation due to structural fixed-cost expansion and mix pressures. The news does not materially alter the thesis: the company remains in a prove-it phase where operating leverage must materialize to justify the multiple.

Implication

Canada Goose's narrative remains one of demand recovery offset by persistent margin headwinds from marketing spend and product mix shift. The Q4 results, while positive on the top line, likely failed to demonstrate the operating leverage needed to break the stock out of its range. With a 75x P/E and net debt/EBITDA near 2x, the equity prices in a profitability improvement that has not yet materialized. Investors should monitor if management provides explicit SG&A efficiency targets in upcoming calls; absent that, the risk of another earnings miss remains high. The only catalyst that could change the thesis is a sustainable improvement in adjusted EBIT margin above 30% while maintaining DTC comp growth, which seems at least two quarters away.

Thesis delta

The Q4 report reinforces the existing WAIT thesis: revenue momentum is intact but operating leverage is not. No shift in the core narrative—still waiting for SG&A growth to slow and for gross margin to stabilize amid mix dilution. The re-assessment window of 3-6 months remains unchanged.